You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Bulk Pharmaceutical API Sources for CLOBEX


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for CLOBEX

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou APIChem Technology ⤷  Get Started Free AC-17990 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A817657 ⤷  Get Started Free
BioChemPartner ⤷  Get Started Free BCP0726000094 ⤷  Get Started Free
BioChemPartner ⤷  Get Started Free BCP9000539 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: CLOBEX

Last updated: July 29, 2025


Introduction

Clobex, a widely prescribed topical corticosteroid, utilizes clobetasol propionate as its active pharmaceutical ingredient (API). As the demand for high-quality APIs escalates, pharmaceutical manufacturers and healthcare providers seek reliable, cost-effective bulk sources for clobetasol propionate. Ensuring consistent supply chains, compliance with regulatory standards, and product efficacy hinges on access to reputable API suppliers. This article delineates key sources, assesses their credibility, and offers strategic insights into sourcing APIs for Clobex production.


Understanding Clobetasol Propionate as API

Clobetasol propionate, a potent corticosteroid, is primarily utilized in treating inflammatory skin conditions such as psoriasis, eczema, and dermatitis. Its API hallmark is high potency combined with excellent stability and efficacy. The manufacturing complexity involves multi-step chemical synthesis, often starting from chlorinated steroids. Consequently, sourcing high-grade, pharmaceutically pure APIs requires stringent quality controls aligned with global standards like USP, EP, or JP.


Global API Manufacturing Hubs and Leading Suppliers

1. India: The Epicenter of API Production

India remains the preeminent source for bulk APIs globally, owing to cost-effective manufacturing, robust regulatory frameworks, and expanding GMP-compliant facilities. Major Indian API manufacturers producing clobetasol propionate include:

  • Sun Pharma: As one of the largest pharmaceutical firms in India, Sun Pharma offers a wide array of APIs, including corticoids like clobetasol propionate. They adhere to international standards and possess WHO-GMP certifications.

  • Jubilant Life Sciences: This company has extensive expertise in steroid APIs and maintains facilities compliant with global standards, offering high-quality bulk clobetasol propionate.

  • Laurus Labs: Known for specialty chemicals, their steroid API portfolio includes clobetasol propionate, emphasizing cost efficiency and regulatory adherence.

Certification and Quality Standards: Most Indian API manufacturers operate under strict GMP guidelines and possess certifications from USFDA, EMA, and other regulatory bodies, ensuring compliance and regulatory acceptance.

2. China: Growing API Manufacturing Powerhouse

Chinese API producers have expanded capabilities in steroid synthesis, largely driven by competitive pricing and rapidly scaling infrastructure.

  • Hengshui Ouhua Pharmaceutical: Known for steroid hormones and intermediates, offering bulk clobetasol propionate with certified quality standards.

  • North China Pharmaceutical Group Corporation (NCPC): A leading state-owned enterprise with significant steroid API manufacturing capacities, focusing on quality and affordability.

Challenges: Some Chinese suppliers face scrutiny over regulatory transparency. Due diligence and comprehensive audits are recommended when sourcing from China to ensure quality compliance.

3. Europe: Established but Higher Cost

European API manufacturers tend to offer premium-quality APIs with a long-standing reputation for stringent regulatory compliance.

  • Evonik Industries: Produces steroid APIs with high purity levels, suitable for markets requiring strict regulatory adherence.

  • Rhone Poulenc (Sanofi): Historically active in steroid hormone synthesis, though some operations have been integrated into larger pharmaceutical units.

Advantages: European suppliers often meet rigorous GMP standards and have extensive regulatory documentation, easing importation into highly regulated markets.


Specialized API Sourcing Considerations

A. Regulatory Compliance and Quality Assurance

Suppliers must provide comprehensive documentation, including batch records, stability data, impurity profiles, and Certificates of Analysis (CoA). Compliance with international pharmacopoeia standards (USP, EP, JP) is non-negotiable for GMP facilities.

B. Supply Chain Reliability

Stability and capacity assurance are critical. Suppliers with diversified manufacturing sites and proven logistics capabilities mitigate risks of shortages or delays.

C. Cost and Lead Time

While Indian and Chinese sources tend to be cost-effective, European manufacturers often command premium pricing aligned with higher regulatory stringency. Lead times vary based on supplier capacity, with advanced planning essential for large-scale procurement.


Emerging Trends in API Sourcing

  • Vertical Integration: Some pharmaceutical companies are investing directly in API manufacturing to ensure supply security and quality control, reducing dependency on third-party suppliers.

  • API Contract Manufacturing: Contract manufacturing organizations (CMOs) specializing in steroid synthesis are gaining prominence, offering customization and compliance support.

  • Regulatory Harmonization: Increasing alignment of regulatory standards facilitates global sourcing, but regional nuances necessitate thorough due diligence.


Supply Chain Challenges and Opportunities

The COVID-19 pandemic highlighted vulnerabilities in global supply chains, leading to increased interest in local manufacturing and strategic stockpiling. Despite challenges, Asia-Pacific, especially India and China, remain dominant in steroid API production. Opportunities exist for North American and European firms to develop regional manufacturing capacities to enhance supply resilience.


Regulatory and Quality Assurance Strategies

Practitioners sourcing APIs for Clobex should prioritize suppliers with validated manufacturing processes, extensive audits, and proven history of regulatory acceptance. Establishing quality agreements, performing on-site inspections, and conducting initial pilot batches ensure compliance before large-scale procurement.


Conclusion

Reliable API sourcing for Clobex requires navigating a complex landscape of global suppliers. Indian and Chinese manufacturers dominate as cost-effective, high-volume sources with expanding quality assurance capabilities. European suppliers offer premium quality but at higher costs. Careful evaluation encompassing regulatory compliance, supply stability, and quality documentation is essential for pharmaceutical companies seeking to amass a secure, compliant API inventory.


Key Takeaways

  • India and China lead globally in bulk clobetasol propionate API production, offering cost-effective options with expanding regulatory compliance.

  • European API manufacturers prioritize quality assurance, suitable for markets with stringent regulatory requirements.

  • Due diligence and quality validation are critical steps prior to engaging with suppliers, including audits and verification of certifications.

  • Supply chain resilience is increasingly vital; consider diversification of suppliers and domestic manufacturing to mitigate risks.

  • Emerging trends favor contract manufacturing and regional API production, supporting secure and compliant supply chains.


FAQs

1. What factors should I consider when choosing an API supplier for Clobex?
Regulatory compliance (GMP certification), quality assurance documentation, supply reliability, cost, lead times, and supplier reputation are paramount.

2. Are Chinese suppliers of clobetasol propionate API regulated?
Many Chinese suppliers operate under GMP and possess international certifications; however, rigorous audits and validation are recommended to ensure compliance.

3. How does European API sourcing differ from Asian options?
European sources often provide higher purity standards, extensive regulatory documentation, and long-standing quality reputations but at higher costs and potentially longer lead times.

4. Is API manufacturing capacity sufficient to meet global Clobex demand?
Major Indian and Chinese manufacturers have substantial capacities, but market fluctuations necessitate early planning and diversified supplier engagement.

5. Can I source API directly from contract manufacturers?
Yes, Contract Manufacturing Organizations (CMOs) specializing in steroid APIs can provide customized production, quality validation, and regulatory support, streamlining procurement.


Sources:

[1] U.S. Pharmacopeia (USP) Monographs and Standards.
[2] European Pharmacopoeia (EP) Guidelines.
[3] Reports on Indian API industry from the Department of Pharmaceuticals, Government of India.
[4] Market analysis reports on steroid API production from GlobalData and ICIS.
[5] Pharmaceutical API supplier directories and certifications from WHO-GMP and ISO.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.